← feed

Is NCT03475862 results overdue?

Yes — results are overdue. Primary completion was 2017-07-31; the FDAAA-801 reporting deadline (2018-07-31) passed 2882 days ago and no results are posted on ClinicalTrials.gov.

Nasal Human Abuse Potential of PTI-821

NCT IDNCT03475862 ↗
SponsorPain Therapeutics (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-07-31 (ACTUAL)
Reporting deadline2018-07-31 (completion + 365d)
Days overdue2882
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 b734d20c4a1f49f9… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03475862. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →